Rosen Law Firm Encourages ADMA Biologics, Inc. Investors to Inquire About Securities Class Action Investigation - ADMA

robot
Abstract generation in progress

The Rosen Law Firm has announced an investigation into potential securities claims against ADMA Biologics, Inc. following allegations of misleading business information. This comes after a short seller report claimed ADMA Biologics engaged in “channel stuffing” which caused the company’s stock to drop. Investors who purchased ADMA Biologics securities are encouraged to contact the law firm to join a potential class action lawsuit.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin